Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease.

Journal of dietary supplements - 1 Mar 2012

Siddique Yasir Hasan, Ara Gulshan, Jyoti Smita, Afzal Mohammad

Abstract excerpt

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons and the aggression of alpha Synuclein (αS) in the brain. Drosophila mutants and transgenes have provided a platform to understand the mechanistic insight associated with the degenerative diseases. A number of polyphenols have been reported to inhibit the αS aggregation resulting in the possible prevention of PD. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Animals, Genetically Modified

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dietary Supplements

Share to Dopaminergic Neurons

Share to Free Radicals

Share to Locomotion

Share to Phytotherapy

Share to Plant Extracts

Source

Identifiers

PMID: 22432798
DOI: 10.3109/19390211.2011.630716

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease.PMID 22432798Read ↗

Protective effect of curcumin in transgenic Drosophila melanogaster model of Parkinson’s diseaseSemantic proximity Read ↗

Ameliorative Role of Nutraceuticals on Neurodegenerative Diseases Using theDrosophila melanogasteras a Discovery Model to Define BioefficacySemantic proximity Read ↗

Nicotine-mediated therapy for Parkinson’s disease in transgenic Caenorhabditis elegans modelSemantic proximity Read ↗

Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.Semantic proximity Read ↗

Saffron ameliorated motor symptoms, short life span and retinal degeneration in Parkinson's disease fly models.Semantic proximity Read ↗

Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease modelsSemantic proximity Read ↗

Curcumin Effectively Rescued Parkinson’s Disease‐Like Phenotypes in a Novel Drosophila melanogaster Model with dUCH KnockdownSemantic proximity Read ↗

High fat diet induces differential age- and gender-dependent changes in neuronal function linked to redox stressSemantic proximity Read ↗

Degradation of alpha-synuclein by dendritic cell factor 1 delays neurodegeneration and extends lifespan in Drosophila.Semantic proximity Read ↗

Age specific neuroprotection of curcumin is through differential modulation of brain dopamine metabolism: Insights from Drosophila model of Parkinson’s diseaseSemantic proximity Read ↗

Fullerenols Prevent Neuron Death and Reduce Oxidative Stress in Drosophila Huntington’s Disease ModelSemantic proximity Read ↗

Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans modelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.